Earnings call Ülker Bisküvi's FY2025 saw 2% revenue growth and resilient market leadership despite a sharp Q4 downturn, driven by weak demand in Turkey and the Middle East. Management attributes ...

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on study results, FDA alignment and a DSMB recommendation. Patients that received 20mg ...